Related Experiment Video
Updated: Apr 27, 2026
07:40
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
5.3K
Pathophysiology of JIA-associated uveitis
Sebastiaan J Vastert1, Pooja Bhat, Debra A Goldstein
1Department of Pediatric Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht , The Netherlands and.
Ocular Immunology and Inflammation
|July 3, 2014
Summary
Juvenile idiopathic arthritis (JIA)-associated uveitis is a complex condition with a poorly understood pathophysiology. Research is exploring immune cells and genetics to find new JIA uveitis treatments.
Area of Science:
- Rheumatology and Ophthalmology
- Immunology
- Genetics
Background:
- Juvenile idiopathic arthritis (JIA)-associated uveitis is a significant cause of long-term ocular damage.
- The underlying pathophysiology of JIA-associated uveitis remains incompletely understood.
- Current understanding integrates genetic predisposition and immune system dysregulation.
Purpose of the Study:
- To review current concepts regarding the pathophysiology of JIA-associated uveitis.
- To highlight the interplay between genetic factors and immune responses in JIA.
- To discuss potential future therapeutic targets based on advancing knowledge.
Main Methods:
- Review of existing literature on JIA and JIA-associated uveitis.
- Analysis of studies focusing on immune cells, including T cell subsets and dendritic cells.
- Consideration of data from experimental animal models of uveitis and human studies of JIA arthritis.
Main Results:
- JIA is a multifactorial and polygenetic disease with a modest genetic contribution to both JIA and associated uveitis.
- Pathophysiological insights are derived from both human studies of JIA arthritis and animal models of uveitis.
- Research has extensively studied adaptive immune system cells, such as regulatory and effector T cells, and antigen-presenting cells.
Conclusions:
- Understanding JIA-associated uveitis requires integrating genetic and immunological perspectives.
- Advances in technology and mechanistic understanding are paving the way for novel therapeutic strategies.
- Further research into immune cell function and genetic underpinnings is crucial for improving patient outcomes.
Related Concept Videos
01:21Acute Pancreatitis II: Pathophysiology
40
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
40
01:17Gastritis-II: Pathophysiology
1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
01:22Myasthenia Gravis ll: Pathophysiology
49
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
01:21Chronic Pancreatitis II: Pathophysiology
25
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
25
01:21Cytotoxic Edema: Pathophysiology
19
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
19
01:26Gastritis II: Pathophysiology
43
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
43